Literature DB >> 8596019

Accessory cell-derived IL-12 and prostaglandin E2 determine the IFN-gamma level of activated human CD4+ T cells.

C M Hilkens1, A Snijders, H Vermeulen, P H van der Meide, E A Wierenga, M L Kapsenberg.   

Abstract

IL-12 and PGE2 are two immunomodulators produced by accessory cells (AC) in response to various stimuli. IL- 12 enhances IFN-gamma production by activated CD4+ T cells, whereas PGE2 inhibits the secretion of this cytokine. Because these AC-derived factors exert clearly opposite modulatory effects on IFN-gamma production, we examined 1) the net-IFN-gamma production of CD4+ T cells, stimulated in the presence of both IL-12 and PGE2, 2) the susceptibility of activated CD4+ T cells in time by adding these modulators at different timepoints after stimulation, and 3) the relative contributions of AC-derived IL-12 and PGE2 to IFN-gamma levels by stimulating CD4+ T cells in the presence of LPS-activated monocytes and inhibitors of PGE2 or IL-12. Here, we demonstrate that 1) IL-12 and PGE2 do not abrogate the modulatory action of each other and that the net-IFN-gamma production is determined by their concentration ratio, 2) T cells become insensitive to PGE2, whereas susceptibility to IL-12 is retained after activation, and 3) activated monocytes potently modulate IFN-gamma levels of stimulated CD4+ T cells via release of IL-12 and PGE2. The relative contributions of these AC-derived factors shift in time, due to different production kinetics, from a dominant IL-12 effect to a mixed IL-12/PGE2 effect. Because the net IFN-gamma production of CD4+ T cells is largely determined by the ratio of IL-12 and PGE2 at the timepoint of T cell activation, an imbalance in the production of these immunomodulators may, therefore, lead to immunologic dysfunction.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8596019

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

Review 1.  Role of dendritic cells: a step forward for the hygiene hypothesis.

Authors:  Xi Yang; Xiaoling Gao
Journal:  Cell Mol Immunol       Date:  2010-11-08       Impact factor: 11.530

2.  Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12.

Authors:  P Panina-Bordignon; D Mazzeo; P D Lucia; D D'Ambrosio; R Lang; L Fabbri; C Self; F Sinigaglia
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

3.  E prostanoid 2 (EP2)/EP4-mediated suppression of antigen-specific human T-cell responses by prostaglandin E2.

Authors:  Mitsuhiro Okano; Yuji Sugata; Tazuko Fujiwara; Rie Matsumoto; Masahiro Nishibori; Kenji Shimizu; Megumi Maeda; Yoshinobu Kimura; Shin Kariya; Hisashi Hattori; Minehiko Yokoyama; Kosuke Kino; Kazunori Nishizaki
Journal:  Immunology       Date:  2006-07       Impact factor: 7.397

4.  Aberrant prostaglandin synthase 2 expression defines an antigen-presenting cell defect for insulin-dependent diabetes mellitus.

Authors:  S A Litherland; X T Xie; A D Hutson; C Wasserfall; D S Whittaker; J X She; A Hofig; M A Dennis; K Fuller; R Cook; D Schatz; L L Moldawer; M J Clare-Salzler
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

5.  PGE(2) transiently enhances DC expression of CCR7 but inhibits the ability of DCs to produce CCL19 and attract naive T cells.

Authors:  Ravikumar Muthuswamy; Jan Mueller-Berghaus; Uwe Haberkorn; Todd A Reinhart; Dirk Schadendorf; Pawel Kalinski
Journal:  Blood       Date:  2010-05-24       Impact factor: 22.113

6.  Augmentation of natural killer cell activity in mice by oral administration of transforming growth factor-beta.

Authors:  S Ishizaka; M Kimoto; S Kanda; S Saito
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

7.  Combined treatment with interleukin-12 and indomethacin promotes increased resistance in BALB/c mice with established Leishmania major infections.

Authors:  Jian Li; Udaikumar M Padigel; Phillip Scott; Jay P Farrell
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

8.  The modulatory effects of prostaglandin-E on cytokine production by human peripheral blood mononuclear cells are independent of the prostaglandin subtype.

Authors:  Maaike M B W Dooper; Lianne Wassink; Laura M'Rabet; Yvo M F Graus
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

9.  Prostaglandin E2 is a potent regulator of interleukin-12- and interleukin-18-induced natural killer cell interferon-gamma synthesis.

Authors:  William Walker; Dino Rotondo
Journal:  Immunology       Date:  2004-03       Impact factor: 7.397

Review 10.  Regulation of T helper cell subsets by cyclooxygenases and their metabolites.

Authors:  Hong Li; Matthew L Edin; Artiom Gruzdev; Jennifer Cheng; J Alyce Bradbury; Joan P Graves; Laura M DeGraff; Darryl C Zeldin
Journal:  Prostaglandins Other Lipid Mediat       Date:  2012-11-28       Impact factor: 3.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.